Orange Healthcare’s ability to tackle the healthcare industry’s challenges with end-to-end machine-to-machine (M2M) solutions highlighted
Orange has been awarded the 2013 Frost & Sullivan Customer Value Leadership Award for M2M in Health, Europe. This award recognizes the work of Orange Healthcare, the division dedicated to the healthcare industry of Orange Business, Orange’s B2B entity, and its ability to provide Orange’s leading machine-to-machine managed services to the healthcare industry. This award also recognizes Orange for “demonstrating excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services and products.”
Frost & Sullivan credits Orange’s performance to in-house eHealth expertise, its holistic machine-to-machine integration into value-added industry solutions, and secure M2M platform dedicated to healthcare. Frost & Sullivan stated: “Due to the highly-specialized nature of M2M applications, it is crucial for providers to have expert knowledge of specific vertical markets. Orange has been closely collaborating with various healthcare ecosystem players for the past 15 years, gaining significant experience related to the provision of integrated technology for providers and patients alike.”
It is this experience that enables Orange to place the customer at the center of its wide range of healthcare solutions, providing secure and interoperable end-to-end connectivity solutions adapted to the specific needs of the customer, from the patient to the healthcare provider.
“We are very pleased to be recognized by Frost & Sullivan for our work at the technological forefront of the healthcare sector, particularly for our M2M solutions,” said Thierry Zylberberg, director of Orange Healthcare. “This award exemplifies the dedication and expertise of our professionals that serve many healthcare industry leaders including Ideal Life and Sorin. The continual increase in healthcare costs coupled with the large number of patients being treated for chronic diseases makes e-health solutions, such as remote medical device monitoring, a significant opportunity for companies to use IT to enable more personalized medical care and improve everyday life for patients.”
The research study concludes: “Orange‘s story clearly proves that designing M2M health solutions based on strong industry expertise and technical capabilities can pave the way to disruptive digital healthcare delivery and enhanced value for customers. [Orange] understands the industry and is capable of facilitating and integrating M2M into healthcare processes. Based on the aforementioned performance drivers, Orange is awarded with the 2013 Frost & Sullivan Customer Value Leadership Award.”